1. Cost considerations: The research, development, production, and promotion of new medical devices require the investment of large amounts of money and resources. The high cost of equipment leads to restricted promotion and limits its popularity.
2. Technological maturity: Compound tumor minimally invasive treatment device (CombiKnife) is in the stage of experimental technology, which requires further research and development, testing and verification to ensure its safety and effectiveness.